{"DataElement":{"publicId":"2725356","version":"1","preferredName":"Protocol Estrogen Receptor Status Progesterone Receptor Status Stratification Factors Status","preferredDefinition":"the status of protocol stratification factors for the estrogen receptor level measured in a primary tumor or in metastases and the progesterone receptor level measured in a primary tumor or in metastases.","longName":"PROT_ER_PGR_STR_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2725354","version":"1","preferredName":"Protocol Estrogen Receptor Status Progesterone Receptor Status Stratification Factors","preferredDefinition":"information related to the protocol stratification factors for the estrogen receptor level measured in a primary tumor or in metastases and the progesterone receptor level measured in a primary tumor or in metastases.","longName":"PROT_ER_PGR_STRAT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2223331","version":"1","preferredName":"Protocol","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.","longName":"C25320","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B105A-B8AD-27F8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2725352","version":"1","preferredName":"Estrogen Receptor Status Progesterone Receptor Status Stratification Factors","preferredDefinition":"The estrogen receptor level measured in a primary tumor or in metastases.  There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and:Indicates the progesterone receptor level measured in a primary tumor or in metastases. (>=10 is positive if measured in fmols/mg cytosol protein; Otherwise use institutional standards):Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"C16150:C16149:C16153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Status","conceptCode":"C16150","definition":"The estrogen receptor level measured in a primary tumor or in metastases.  There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and is characterized by an ER+ status.  However, these two variants tend to overlap with respect to age, so it is possible for a young woman to have a \"late-onset\" form of breast cancer and for an older woman to have an \"early-onset\" variant of the disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Progesterone Receptor Status","conceptCode":"C16149","definition":"Indicates the progesterone receptor level measured in a primary tumor or in metastases. (>=10 is positive if measured in fmols/mg cytosol protein; Otherwise use institutional standards)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification Factors","conceptCode":"C16153","definition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E3B1BD-7F21-62A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-29","modifiedBy":"ONEDATA","dateModified":"2008-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E3B1BD-7F32-62A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2725355","version":"1","preferredName":"Stratification Factors Status","preferredDefinition":"A condition or state at a particular time.","longName":"STRAT_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Both or either positive or unknown","valueDescription":"Both or either positive or unknown","ValueMeaning":{"publicId":"2725357","version":"1","preferredName":"Both or either positive or unknown","longName":"2725357","preferredDefinition":"Both or either positive or unknown","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E45999-B436-4EAC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"44E3C9A3-41FB-653F-E044-0003BA3F9857","beginDate":"2008-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-29","modifiedBy":"ONEDATA","dateModified":"2008-01-29","deletedIndicator":"No"},{"value":"Both negative","valueDescription":"BOTH NEGATIVE","ValueMeaning":{"publicId":"2561422","version":"1","preferredName":"BOTH NEGATIVE","longName":"2561422","preferredDefinition":"BOTH NEGATIVE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BCFB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-02","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"44E3C9A3-4207-653F-E044-0003BA3F9857","beginDate":"2008-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-29","modifiedBy":"ONEDATA","dateModified":"2008-01-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E3C208-7555-6380-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-29","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811964","version":"1","longName":"Tumor Markers","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"ER/PgR","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"44E3C9A3-41E1-653F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-29","modifiedBy":"CAMPBELB","dateModified":"2008-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}